CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Cencora, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$340.00−0.92 (-0.27%)
Close on Oct 19, 2026
- Market cap
- $65.94B
- P/E (TTM)
- 25.2
- Dividend yield
- 0.65%
Cencora, Inc. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 4.0%
- Operating margin
- 0.9%
- Net margin
- 0.8%
- Return on equity, FY2025
- 144.3%
Financial strength
- Current ratio
- 0.93
- Debt to equity
- 3.84
- Debt to assets
- 14.0%
- Cash to current liabilities
- 4.8%
Valuation
- P/E ratio
- 25.2
- Price to sales
- 0.20
- Price to book
- 21.61
- Dividend yield
- 0.65%